PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 1-20 of 72

    April 05, 2016 Drug Alert: Important Prescribing Information

    Humulin® R U-500 KwikPen®

    Lilly USA, LLC

    March 23, 2016 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    FARYDAK® (panobinostat)

    Novartis Pharmaceuticals Corporation

    March 08, 2016 Drug Alert: Important Drug Warning

    ERIVEDGE® (vismodegib)

    Genentech, Inc.

    February 23, 2016 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    FARYDAK® (panobinostat)

    Novartis Pharmaceuticals Corporation

    November 19, 2015 Drug Alert: Important Prescribing Information

    Clozapine REMS

    Various

    October 30, 2015 Drug Alert: Important Prescribing Information

    Clozapine REMS

    Various

    October 12, 2015 Drug Alert: Important Prescribing Information

    Clozapine REMS

    Various

    September 17, 2015 Drug Alert: Important Prescribing Information

    Clozapine REMs

    Various

    September 15, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    TRULICITY™ (dulaglutide)

    Eli Lilly and Company

    August 03, 2015 Drug Alert: Important Prescribing Information

    Humalog KwikPen®, 200 units/mL, (Humalog® U-200 KwikPen®)

    Lilly USA, LLC

    July 13, 2015 Drug Alert: Important Drug Information

    Xeljanz® (tofacitinib)

    Pfizer, Inc.

    July 01, 2015 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    June 29, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Symlin® (pramlintide acetate) injection

    AstraZeneca

    June 26, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Afrezza® (insulin human) Inhalation Powder

    sanofi-aventis U.S. LLC

    June 10, 2015 Drug Alert: Important Drug Warning

    Gilenya® (fingolimod)

    Novartis Pharmaceuticals Corporation

    June 03, 2015 Drug Alert: Important Prescribing Information

    VALCYTE® (valganciclovir)

    Genentech, Inc.

    March 13, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    FARYDAK® (panobinostat)

    Novartis Pharmaceuticals Corporation

    January 28, 2015 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Afrezza® (insulin human) Inhalation Powder

    sanofi-aventis U.S. LLC

    November 10, 2014 Drug Alert: Important Drug Information

    Xeljanz® (tofacitinib)

    Pfizer, Inc.

    Results 1-20 of 72